The US Food and Drug Administration (FDA) has warned an oncology drug company for repeatedly overstating the efficacy of its drug in advertisements while failing to adequately disclose the associated ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...

In a significant move to safeguard public health, the U.S. Food and Drug Administration (FDA) has issued warning letters to seven companies accused of illegally marketing products containing a ...

New Jersey-based AACE Pharmaceuticals has been slammed in an FDA warning letter citing significant violations by its contract manufacturer Brassica Pharma, including substandard sanitary conditions ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...